Kourounakis P N, Rekka E, Demopoulos V J, Retsas S
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Thessaloniki, Greece.
Eur J Drug Metab Pharmacokinet. 1991 Jan-Mar;16(1):9-13. doi: 10.1007/BF03189868.
The effect of the position of the cyano-group of several cyanopregnenolones on the body's resistance to drugs and on drug metabolism was investigated. Female rats were pretreated with 2 alpha-, 6-, 16 alpha-, 17 alpha-cyano- or 16 alpha-cyanomethyl-pregnenolone or with pregnenolone, and the (in vivo) resistance to zoxazolamine, digitoxin and indomethacin, as well as the in vitro drug metabolism (post mitochondrial fraction) of zoxazolamine and ethylmorphine were determined. It was found that the 16-derivative was the most active in this respect, the 2- and 17-cyanopregnenolones were less active but significantly potent compared to controls, while the 6-cyano, the 16-cyanomethyl derivatives and pregnenolone were essentially inactive. These differences were explained in terms of an effective or poor fit of the steroids to their receptor. The poor performance of pregnenolone-16 alpha-acetonitrile was attributed to electronic effects. A hypothesis of some structural features of the receptor site for its interaction with the cyanopregnenolone inducers was presented.
研究了几种氰基孕烯醇酮的氰基位置对机体药物耐受性及药物代谢的影响。给雌性大鼠预先注射2α-、6-、16α-、17α-氰基-或16α-氰甲基-孕烯醇酮或孕烯醇酮,然后测定其对唑沙宗、洋地黄毒苷和吲哚美辛的(体内)耐受性,以及唑沙宗和乙基吗啡的体外药物代谢(线粒体后组分)。结果发现,16-衍生物在这方面活性最高,2-和17-氰基孕烯醇酮活性较低,但与对照组相比有显著效力,而6-氰基、16-氰甲基衍生物和孕烯醇酮基本无活性。这些差异用甾体与受体的有效或不良契合来解释。孕烯醇酮-16α-乙腈表现不佳归因于电子效应。提出了受体位点与氰基孕烯醇酮诱导剂相互作用的一些结构特征的假说。